United Health Products Announces Completion of Human Trial Study
28 août 2019 08h00 HE
|
United Health Products Inc.
HENDERSON, Nev., Aug. 28, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that...
United Health Products Announces Completion of Pathology and Study of Preclinical Bone Application of HemoStyp®
14 août 2019 12h45 HE
|
United Health Products Inc.
HENDERSON, Nev., Aug. 14, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the...
United Health Products Files New Patent Application Method of Forming and Using a Hemostatic Hydrocolloid
08 août 2019 09h00 HE
|
United Health Products Inc.
HENDERSON, Nev., Aug. 08, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, today announced that it has filed a...
United Health Products Announces the Completion of Human Trial Surgery Enrollment
05 août 2019 15h54 HE
|
United Health Products Inc.
HENDERSON, Nev., Aug. 05, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
United Health Products Issues Shareholder Update
09 juil. 2019 09h00 HE
|
United Health Products Inc.
HENDERSON, Nev., July 09, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives
07 mai 2019 08h00 HE
|
United Health Products Inc.
HENDERSON, Nev., May 07, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the...
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Générale’s Strategic Review
24 avr. 2019 08h00 HE
|
United Health Products Inc.
HENDERSON, Nev., April 24, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
United Health Products Announces 2018 Results
02 avr. 2019 08h00 HE
|
United Health Products Inc.
HENDERSON, Nev., April 02, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
United Health Products to Hold Conference Call on December 20, 2018 to Discuss Recent Corporate Developments and Provide Year End Update
17 déc. 2018 13h37 HE
|
United Health Products Inc.
HENDERSON, Nev., Dec. 17, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), a manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...
United Health Products Retains Legal Counsel Ruskin Moscou Faltischek P.C to Assist in Strategic Review
02 nov. 2018 09h00 HE
|
United Health Products Inc.
HENDERSON, Nev., Nov. 02, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the...